99% Savings - Buy Just @1 Rs X
Symbiva 400 Octacap is a commercial drug that is prescribed in the form of Capsule. It is typically used for the treatment of Asthma. Other than this, Symbiva 400 Octacap has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Symbiva 400 Octacap depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Symbiva 400 Octacap include Nasopharyngitis, Headache, Back Pain. While these are the most often observed Symbiva 400 Octacap side effects, there are can be others also. These have been listed below. Normally, these side effects of Symbiva 400 Octacap are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Symbiva 400 Octacap's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Symbiva 400 Octacap's effects on the liver, heart and kidney are discussed below in the Symbiva 400 Octacap related warnings section.
Other conditions have been mentioned below in the Symbiva 400 Octacap contraindications section.
Drug reaction of Symbiva 400 Octacap with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Symbiva 400 Octacap is considered safe while driving, and is addictive.
Symbiva 400 Octacap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Symbiva 400 Octacap safe for pregnant women?
Symbiva may have some side effects during pregnancy. Pregnant women should discontinue the use of Symbiva, and talk to their doctor, if they notice any discomfort.
Is the use of Symbiva 400 Octacap safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Symbiva. Immediately discontinue Symbiva if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Symbiva 400 Octacap on the Kidneys?
Symbiva does not damage the kidneys.
What is the effect of Symbiva 400 Octacap on the Liver?
Symbiva is not harmful for the liver.
What is the effect of Symbiva 400 Octacap on the Heart?
Symbiva may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Symbiva 400 Octacap unless your doctor advises you to do so -
Is this Symbiva 400 Octacap habit forming or addictive?
Symbiva 400 Octacap is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Symbiva 400 Octacap since it will not make you feel sleepy.
Is it safe?
Yes, but consume Symbiva 400 Octacap only on doctor's advice.
Is it able to treat mental disorders?
Symbiva 400 Octacap is unable to treat or cure mental disorders.
Interaction between Food and Symbiva 400 Octacap
Taking Symbiva 400 Octacap with food does not harm your health.
Interaction between Alcohol and Symbiva 400 Octacap
Taking Symbiva 400 Octacap with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca